Trials / Completed
CompletedNCT02146209
Study to Determine the Equivalence of Three Products Containing Metronidazole Benzoate.
Comparative Randomized, Single Dose, Three-Period Crossover Open-Label Study to Determine the Bioequivalence Of Terix Labs Ltd Metronidazole Benzoate (400 mg Metronidazole Per Sachet Oral Granules (Formula A)) Relative to 500 mg From Sanofi-aventis Flagyl 125 mg/5 ml (125 mg Metronidazole Per 5 ml Suspension (Formula B)) and Zentiva Flagyl™ 400 mg Tablets (400 mg Metronidazole Per Film Coated Tablets (Formula C)) , After an Oral Administration to Healthy Adults Under Fasting Conditions
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 6 (actual)
- Sponsor
- Verisfield UK Ltd. Greek Branch · Industry
- Sex
- All
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to determine whether Terix Labs Ltd Metronidazole benzoate (400 mg Metronidazole Per Sachet Oral Granules) is bioequivalent to 500 mg Sanofi-aventis Flagyl 125 mg/5 ml (125 mg Metronidazole Per 5 ml Suspension) and to Zentiva Flagyl™ 400 mg Tablets (400 mg Metronidazole Per Film Coated Tablets).
Detailed description
This study is a pilot study exploited for exploratory purposes to compare the absorption and disposition kinetics of three products containing metronidazole under fasting conditions. These products are: Metronidazole benzoate (formula A), Test product manufactured by ONE PHARMA, Greece. Flagyl 125 mg/5 ml (formula B), a Reference product manufactured by Unither Liquid Manufacturing, France and Flagyl™ 400 mg Tablets (formula C), a Reference product manufactured by Famar Health Care Services, Spain. The bioequivalence of a single 400 mg dose of products A and C, and a single 500 mg dose of product B will be assessed by comparing the pharmacokinetic parameters derived from the plasma concentration-time profiles for metronidazole.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Metronidazole benzoate | Single oral dose of 400 mg |
| DRUG | Flagyl 125 mg/5 ml oral suspension | Single oral dose of 500 mg (20 ml suspension) |
| DRUG | Flagyl 400 mg Tablets | Single oral dose of 400 mg |
Timeline
- Start date
- 2014-06-01
- Primary completion
- 2014-06-01
- Completion
- 2014-06-01
- First posted
- 2014-05-23
- Last updated
- 2014-08-01
Locations
1 site across 1 country: Jordan
Source: ClinicalTrials.gov record NCT02146209. Inclusion in this directory is not an endorsement.